THE MESORECTUM IN RECTAL-CANCER SURGERY - THE CLUE TO PELVIC RECURRENCE
THE MESORECTUM IN RECTAL-CANCER SURGERY - THE CLUE TO PELVIC RECURRENCE
复制标题
DOI：
10.1002/bjs.1800691019
复制
发表时间：
1982-01-01
影响因子：
9.6
通讯作者：
RYALL, RDH
中科院分区：
文献类型：
--
作者：
HEALD, RJ;HUSBAND, EM;RYALL, RDH
五例中，腺癌的微小病灶已被证明在直肠系膜几厘米远的直肠癌明显的下边缘。在其中2例中，没有其他肿瘤淋巴扩散的证据。在传统的前切除术中，这些组织大部分保留在骨盆内，这表明这些病灶可能导致缝合线或骨盆复发。因此，直肠系膜的全切除已经作为100多个连续前切除术的一部分进行。其中50例被归类为“治愈性”或“可想象治愈性”手术，现已随访2年以上，无盆腔或缝钉线复发。
Five cases are described where minute foci of adenocarcinoma have been demonstrated in the mesorectum several centimetres distal to the apparent lower edge of a rectal cancer. In 2 of these there was no other evidence of lymphatic spread of the tumour. In orthodox anterior resection much of this tissue remains in the pelvis, and it is suggested that these foci might lead to suture-line or pelvic recurrence. Total excision of the mesorectum has, therefore, been carried out as a part of over 100 consecutive anterior resections. Fifty of these, which were classified as ‘curative’ or ‘conceivably curative’ operations, have now been followed for over 2 years with no pelvic or staple-line recurrence.